Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_assertion type Assertion NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_head.
- NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_assertion wasGeneratedBy ECO_0000203 NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_provenance.
- NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_assertion wasDerivedFrom befree-20150227 NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_provenance.
- NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_assertion SIO_000772 24011934 NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_provenance.
- NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_assertion evidence source_evidence_literature NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_provenance.
- NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_assertion description "[These studies identify dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective new approach to treating ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622628.RA1fzNreEA4yD6k7aWxOgeKNEDP052VE_wrdQLcCz3QiA130_provenance.